1/8
Looks like no tags are added yet.
SGLT2 inhibitor drug
canagliflozin (Invokana)
Indication of SGLT2 inhibitor
Type 2 diabetes mellitus
Mechanism of SGLT2 inhibitor
Inhibits SGLT2 in the proximal renal tubules, reducing
reabsorption of filtered glucose from the tubular
lumen
Inhibits glucose resorption in the distal tubule of nephron
Black Box Warnings of SGLT2 inhibitor
none
Contraindications of SGLT2 inhibitor
Severe renal impairment (ESRD, dialysis); Serious hypersensitivity (eg, anaphylaxis, angioedema)
Common adr of SGLT2 inhibitor
Urinary tract infection, hypotension, hyperkalemia, dehydration, genitourinary fungal infections
rare adr of SGLT2 inhibitor
Euglycemic ketoacidosis, acute renal failure, bone fracture, perineal necrotizing fasciitis, Risk of lower limb amputations
Counseling points of SGLT2 inhibitor
Take before breakfast daily. Ensure adequate hydration on the drug and adequate genital
hygiene
Other drugs in class SGLT2 inhibitor
Dapagliflozin (Farxiga), Empagliflozin (Jardiance), Ertugliflozin (Steglatro), Bexagliflozin (Brenzavvy)